even in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.
even in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.
even in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.
even in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.
Clinical & Research Update: Pediatric Liver Tumors - A Case-Based Discussion with Drs. Katherine Somers & Alex Bondoc
▶Ep 14 · 14:51
clinicalRib fractures or vertebral fractures are fairly common as a presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 14 · 14:51
quoterib fractures or, uh, vertebrate vertebral fractures are actually fairly common as a essentially presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 14 · 14:51
clinicalRib fractures or vertebral fractures are fairly common as a presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 14 · 14:51
quoterib fractures or, uh, vertebrate vertebral fractures are actually fairly common as a essentially presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 14 · 15:29
clinicalFractures in hepatoblastoma patients will heal as they go through their therapy, and kids tend to be rather unbothered by their fractures once cancer therapy is underway.↗
▶Ep 14 · 15:29
clinicalFractures in hepatoblastoma patients will heal as they go through their therapy, and kids tend to be rather unbothered by their fractures once cancer therapy is underway.↗
▶Ep 14 · 15:43
clinicalPrecocious puberty in a Tanner stage one patient is a sign that should prompt consideration of underlying malignancy on the differential.↗
▶Ep 14 · 15:43
clinicalPrecocious puberty in a Tanner stage one patient is a sign that should prompt consideration of underlying malignancy on the differential.↗
▶Ep 14 · 19:39
epidemiologicalWeight loss or sarcopenia during active cancer therapy is associated with poor outcomes across all pediatric cancer diagnoses.↗
▶Ep 14 · 19:39
epidemiologicalWeight loss or sarcopenia during active cancer therapy is associated with poor outcomes across all pediatric cancer diagnoses.↗
▶Ep 14 · 19:39
quoteThere are excellent data across multiple pediatric cancer types that demonstrate that weight loss or sarcopenia during active cancer therapy is associated with poor outcomes across the boards for all diagnoses.↗
▶Ep 14 · 19:39
quoteThere are excellent data across multiple pediatric cancer types that demonstrate that weight loss or sarcopenia during active cancer therapy is associated with poor outcomes across the boards for all diagnoses.↗
▶Ep 14 · 19:52
clinicalAdvanced nutritional support is a key part of care for pediatric liver tumor patients to ready them for surgical interventions.↗
▶Ep 14 · 19:52
clinicalAdvanced nutritional support is a key part of care for pediatric liver tumor patients to ready them for surgical interventions.↗
▶Ep 14 · 34:31
clinicalFor patients with successful primary tumor resection, the first surgical goal is always primary tumor resection whenever possible.↗
▶Ep 14 · 34:31
clinicalFor patients with successful primary tumor resection, the first surgical goal is always primary tumor resection whenever possible.↗
clinicalIn patients with known vascular invasion and metastatic disease, continuing chemotherapy despite beautiful response helps weed out any remaining circulating cells that remain active.↗
▶Ep 14 · 35:47
clinicalIn patients with known vascular invasion and metastatic disease, continuing chemotherapy despite beautiful response helps weed out any remaining circulating cells that remain active.↗
▶Ep 14 · 39:20
quoteeven in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.↗
▶Ep 14 · 39:20
clinicalEven when one side of the chest shows no viable tumor after chemotherapy, the other side is still cleared surgically because that is the best pathway to long-term disease control and maintenance of remission.↗
▶Ep 14 · 39:20
clinicalEven when one side of the chest shows no viable tumor after chemotherapy, the other side is still cleared surgically because that is the best pathway to long-term disease control and maintenance of remission.↗
▶Ep 14 · 39:20
quoteeven in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.↗
▶Ep 14 · 48:44
epidemiologicalKnown risk factors for developing hepatoblastoma include Beckwith-Wiedemann syndrome, hemihypertrophy syndromes, trisomy 18, autosomal recessive polycystic kidney disease, and extreme prematurity.↗
▶Ep 14 · 48:44
epidemiologicalKnown risk factors for developing hepatoblastoma include Beckwith-Wiedemann syndrome, hemihypertrophy syndromes, trisomy 18, autosomal recessive polycystic kidney disease, and extreme prematurity.↗
▶Ep 14 · 49:18
quoteIt's not just the autosomal recessive, uh, polycystic Kidney disease children. It's really end-stage renal disease early in life. We are noting an increased incidence of hepatblastoma patients.↗
▶Ep 14 · 49:18
epidemiologicalIt's not just autosomal recessive polycystic kidney disease children who develop hepatoblastoma; there is increased incidence in end-stage renal disease early in life.↗
▶Ep 14 · 49:18
quoteIt's not just the autosomal recessive, uh, polycystic Kidney disease children. It's really end-stage renal disease early in life. We are noting an increased incidence of hepatblastoma patients.↗
▶Ep 14 · 49:18
epidemiologicalIt's not just autosomal recessive polycystic kidney disease children who develop hepatoblastoma; there is increased incidence in end-stage renal disease early in life.↗
▶Ep 14 · 49:39
clinicalCisplatin's primary toxicity is renal, and it can cause chronic kidney disease.↗
▶Ep 14 · 49:39
clinicalCisplatin's primary toxicity is renal, and it can cause chronic kidney disease.↗
▶Ep 14 · 50:02
clinicalPlatinum-based chemotherapy can be delivered to patients on peritoneal dialysis using advanced pharmacokinetic and pharmacodynamic modeling systems without typical mandated hyperhydration.↗
▶Ep 14 · 50:02
clinicalPlatinum-based chemotherapy can be delivered to patients on peritoneal dialysis using advanced pharmacokinetic and pharmacodynamic modeling systems without typical mandated hyperhydration.↗
▶Ep 14 · 50:59
clinicalHepatoblastoma typically presents in the toddler range (first and second year of life), but predisposed patients can develop it as early as congenital or immediately post-delivery.↗
▶Ep 14 · 50:59
clinicalHepatoblastoma typically presents in the toddler range (first and second year of life), but predisposed patients can develop it as early as congenital or immediately post-delivery.↗
▶Ep 14 · 51:20
clinicalFor known predisposition patients, screening protocol includes ultrasound and alpha-fetoprotein levels, taking into account that AFP has a very different range of normal values in the first months of life.↗
▶Ep 14 · 51:20
clinicalFor known predisposition patients, screening protocol includes ultrasound and alpha-fetoprotein levels, taking into account that AFP has a very different range of normal values in the first months of life.↗
▶Ep 14 · 1:00:58
clinicalVincristine-irinotecan is a less intensive regimen that can be used as maintenance therapy while waiting for organ offers during transplant listing.↗
▶Ep 14 · 1:00:58
clinicalVincristine-irinotecan is a less intensive regimen that can be used as maintenance therapy while waiting for organ offers during transplant listing.↗
▶Ep 14 · 1:04:50
clinicalEvery child with a new cancer diagnosis meets with oncology genetic counseling team for complete genetic testing including germline testing if something is identified.↗
▶Ep 14 · 1:04:50
clinicalEvery child with a new cancer diagnosis meets with oncology genetic counseling team for complete genetic testing including germline testing if something is identified.↗
Clinical & Research Update: Pediatric Liver Tumors - A Case-Based Discussion with Drs. Katherine Somers & Alex Bondoc
▶Ep 17 · 14:51
clinicalRib fractures or vertebral fractures are fairly common as a presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 17 · 14:51
clinicalRib fractures or vertebral fractures are fairly common as a presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 17 · 14:51
quoterib fractures or, uh, vertebrate vertebral fractures are actually fairly common as a essentially presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 17 · 14:51
quoterib fractures or, uh, vertebrate vertebral fractures are actually fairly common as a essentially presentation factor with hepatic tumors in young children, particularly hepatoblastoma.↗
▶Ep 17 · 15:29
clinicalFractures in hepatoblastoma patients will heal as they go through their therapy, and kids tend to be rather unbothered by their fractures once cancer therapy is underway.↗
▶Ep 17 · 15:29
clinicalFractures in hepatoblastoma patients will heal as they go through their therapy, and kids tend to be rather unbothered by their fractures once cancer therapy is underway.↗
▶Ep 17 · 15:43
clinicalPrecocious puberty in a Tanner stage one patient is a sign that should prompt consideration of underlying malignancy on the differential.↗
▶Ep 17 · 15:43
clinicalPrecocious puberty in a Tanner stage one patient is a sign that should prompt consideration of underlying malignancy on the differential.↗
▶Ep 17 · 19:39
quoteThere are excellent data across multiple pediatric cancer types that demonstrate that weight loss or sarcopenia during active cancer therapy is associated with poor outcomes across the boards for all diagnoses.↗
▶Ep 17 · 19:39
quoteThere are excellent data across multiple pediatric cancer types that demonstrate that weight loss or sarcopenia during active cancer therapy is associated with poor outcomes across the boards for all diagnoses.↗
▶Ep 17 · 19:39
epidemiologicalWeight loss or sarcopenia during active cancer therapy is associated with poor outcomes across all pediatric cancer diagnoses.↗
▶Ep 17 · 19:39
epidemiologicalWeight loss or sarcopenia during active cancer therapy is associated with poor outcomes across all pediatric cancer diagnoses.↗
▶Ep 17 · 19:52
clinicalAdvanced nutritional support is a key part of care for pediatric liver tumor patients to ready them for surgical interventions.↗
▶Ep 17 · 19:52
clinicalAdvanced nutritional support is a key part of care for pediatric liver tumor patients to ready them for surgical interventions.↗
▶Ep 17 · 34:31
clinicalFor patients with successful primary tumor resection, the first surgical goal is always primary tumor resection whenever possible.↗
▶Ep 17 · 34:31
clinicalFor patients with successful primary tumor resection, the first surgical goal is always primary tumor resection whenever possible.↗
clinicalIn patients with known vascular invasion and metastatic disease, continuing chemotherapy despite beautiful response helps weed out any remaining circulating cells that remain active.↗
▶Ep 17 · 35:47
clinicalIn patients with known vascular invasion and metastatic disease, continuing chemotherapy despite beautiful response helps weed out any remaining circulating cells that remain active.↗
▶Ep 17 · 39:20
quoteeven in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.↗
▶Ep 17 · 39:20
clinicalEven when one side of the chest shows no viable tumor after chemotherapy, the other side is still cleared surgically because that is the best pathway to long-term disease control and maintenance of remission.↗
▶Ep 17 · 39:20
quoteeven in a patient such as this where we know the first side of the chest had no viable tumor, we still go back and clear the other side of the chest, um, because that is our best pathway to long-term disease control and maintenance of remission.↗
▶Ep 17 · 39:20
clinicalEven when one side of the chest shows no viable tumor after chemotherapy, the other side is still cleared surgically because that is the best pathway to long-term disease control and maintenance of remission.↗
▶Ep 17 · 48:44
epidemiologicalKnown risk factors for developing hepatoblastoma include Beckwith-Wiedemann syndrome, hemihypertrophy syndromes, trisomy 18, autosomal recessive polycystic kidney disease, and extreme prematurity.↗
▶Ep 17 · 48:44
epidemiologicalKnown risk factors for developing hepatoblastoma include Beckwith-Wiedemann syndrome, hemihypertrophy syndromes, trisomy 18, autosomal recessive polycystic kidney disease, and extreme prematurity.↗
▶Ep 17 · 49:18
quoteIt's not just the autosomal recessive, uh, polycystic Kidney disease children. It's really end-stage renal disease early in life. We are noting an increased incidence of hepatblastoma patients.↗
▶Ep 17 · 49:18
epidemiologicalIt's not just autosomal recessive polycystic kidney disease children who develop hepatoblastoma; there is increased incidence in end-stage renal disease early in life.↗
▶Ep 17 · 49:18
quoteIt's not just the autosomal recessive, uh, polycystic Kidney disease children. It's really end-stage renal disease early in life. We are noting an increased incidence of hepatblastoma patients.↗
▶Ep 17 · 49:18
epidemiologicalIt's not just autosomal recessive polycystic kidney disease children who develop hepatoblastoma; there is increased incidence in end-stage renal disease early in life.↗
▶Ep 17 · 49:39
clinicalCisplatin's primary toxicity is renal, and it can cause chronic kidney disease.↗
▶Ep 17 · 49:39
clinicalCisplatin's primary toxicity is renal, and it can cause chronic kidney disease.↗
▶Ep 17 · 50:02
clinicalPlatinum-based chemotherapy can be delivered to patients on peritoneal dialysis using advanced pharmacokinetic and pharmacodynamic modeling systems without typical mandated hyperhydration.↗
▶Ep 17 · 50:02
clinicalPlatinum-based chemotherapy can be delivered to patients on peritoneal dialysis using advanced pharmacokinetic and pharmacodynamic modeling systems without typical mandated hyperhydration.↗
▶Ep 17 · 50:59
clinicalHepatoblastoma typically presents in the toddler range (first and second year of life), but predisposed patients can develop it as early as congenital or immediately post-delivery.↗
▶Ep 17 · 50:59
clinicalHepatoblastoma typically presents in the toddler range (first and second year of life), but predisposed patients can develop it as early as congenital or immediately post-delivery.↗
▶Ep 17 · 51:20
clinicalFor known predisposition patients, screening protocol includes ultrasound and alpha-fetoprotein levels, taking into account that AFP has a very different range of normal values in the first months of life.↗
▶Ep 17 · 51:20
clinicalFor known predisposition patients, screening protocol includes ultrasound and alpha-fetoprotein levels, taking into account that AFP has a very different range of normal values in the first months of life.↗
▶Ep 17 · 1:00:58
clinicalVincristine-irinotecan is a less intensive regimen that can be used as maintenance therapy while waiting for organ offers during transplant listing.↗
▶Ep 17 · 1:00:58
clinicalVincristine-irinotecan is a less intensive regimen that can be used as maintenance therapy while waiting for organ offers during transplant listing.↗
▶Ep 17 · 1:04:50
clinicalEvery child with a new cancer diagnosis meets with oncology genetic counseling team for complete genetic testing including germline testing if something is identified.↗
▶Ep 17 · 1:04:50
clinicalEvery child with a new cancer diagnosis meets with oncology genetic counseling team for complete genetic testing including germline testing if something is identified.↗
